Skip to main content
. Author manuscript; available in PMC: 2022 Jul 19.
Published in final edited form as: Pharm Res. 2022 Mar 3;39(7):1587–1598. doi: 10.1007/s11095-022-03218-w

Table 4.

In Vitro and in Vivo Drug Development Parameters of Compound 11a

Structure LogP (octanol-water) fu Brain and plasma Pe in-vitro (cm/sec) Kin 30 min(μL.g−1.min−1) A50 (μ) Brain concentration 30 min (μM)
graphic file with name nihms-1822314-t0011.jpg 1.14 ± 0.1 0.062 ± 0.011 & 0.41 ± 0.081 18.97 ± 0.9 × 10−6 5.03 ± 1.01 7 ± 1.76 0.26 ± 0.07

Data represents the mean ± SD (n = 4–6)